Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Oxford’s PepGen Launches Into DMD With Next-Gen Oligonucleotide Platform
Aims To Challenge Sarepta
Dec 10 2020
•
By
Andrew McConaghie
PepGen's chief executive Caroline Godfrey.
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip